AONC (American Oncology Network) FCF Margin % : -7.34% (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is American Oncology Network FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. American Oncology Network's Free Cash Flow for the three months ended in Sep. 2024 was $-35 Mil. American Oncology Network's Revenue for the three months ended in Sep. 2024 was $470 Mil. Therefore, American Oncology Network's FCF Margin % for the quarter that ended in Sep. 2024 was -7.34%.

As of today, American Oncology Network's current FCF Yield % is -32.50%.

The historical rank and industry rank for American Oncology Network's FCF Margin % or its related term are showing as below:

AONC' s FCF Margin % Range Over the Past 10 Years
Min: -3.67 Med: -1.8 Max: 3.45
Current: -2.9

During the past 4 years, the highest FCF Margin % of American Oncology Network was 3.45%. The lowest was -3.67%. And the median was -1.80%.

AONC's FCF Margin % is ranked worse than
66.37% of 672 companies
in the Healthcare Providers & Services industry
Industry Median: 2.175 vs AONC: -2.90

American Oncology Network FCF Margin % Historical Data

The historical data trend for American Oncology Network's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Oncology Network FCF Margin % Chart

American Oncology Network Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

3.45

-3.67

-1.22

-2.38

American Oncology Network Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial						-1.94	-4.54	11.25	-8.75	-7.34

Competitive Comparison of American Oncology Network's FCF Margin %

For the Medical Care Facilities subindustry, American Oncology Network's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Oncology Network's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Oncology Network's FCF Margin % distribution charts can be found below:

* The bar in red indicates where American Oncology Network's FCF Margin % falls into.

Save

American Oncology Network FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

American Oncology Network's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-30.401	/	1279.185
	=	-2.38 %

American Oncology Network's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-34.531	/	470.279
	=	-7.34 %

American Oncology Network FCF Margin % Related Terms

Thank you for viewing the detailed overview of American Oncology Network's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oncology Network Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » American Oncology Network Inc (OTCPK:AONC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913

Website

https://www.aoncology.com

American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care needed to achieve optimal health outcomes.

Executives

Stephen Divers	director, officer: Chief Medical Officer	133 HARMONY PARK CIRCLE, HOT SPRINGS AZ 71913
Todd Schonherz	director, officer: Chief Executive Officer	14543 GLOBAL PARKWAY, 2ND FLOOR, FORT MEYERS FL 33913
Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
David H Gould	officer: Chief Financial Officer	7370 COLLEGE PARKWAY, SUITE 207, FORT MEYERS FL 33907
Erica Mallon	officer: General Counsel	14543 GLOBAL PARKWAY, SUITE 110, FORT MEYERS FL 33913
Shalin Shah	director	3402 W DR. MARTIN LUTHER KING JR. BLVD, TAMPA FL 33607
Vipul M Patel	director	11704 SE 15TH CIRCLE, OCALA FL 34480
Vance Wright-browne	director	22395 EDGEWATER DRIVE, PORT CHARLOTTE FL 33980
James Stith	director	ONE LETTERMAN DRIVE, CM200, SAN FRANCISCO CA 94129
Aea Growth Equity Fund Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Aea Growth Equity Fund (parallel) Lp	10 percent owner	520 MADISON AVE, 40TH FLOOR, NEW YORK NY 10022
Ravi Yang Sarin	director	C/O ARES MANAGEMENT LLC, 2000 AVENUE OF THE STARS, 12TH FLOOR, LOS ANGELES CA 90067
Brian R Hoesterey	10 percent owner	C/O AEA INVESTORS LP, 666 FIFTH AVENUE, 36TH FLOOR, NEW YORK NY 10103
Kevin Nazemi	director, officer: Chief Executive Officer	10485 NE 6TH ST, UNIT 3930, BELLEVUE WA 98004